More Biopharma Stock Ideas from Q3 Hedge Fund Activity
- BPIQ

- Dec 20, 2023
- 2 min read
You can find updated Q3 bioHF holdings data at app.bpiq.com/hedgefunds
Check out the ticker screener
If you are an Elite or Amp subscriber ...
Check out the tables at the links on the left menu under "Hedge Funds"
If not, sign up today HERE
Our goal is to help you make $$ investing in biopharma
That's why we follow top biopharma hedge funds (bioHFs) ^1
Here are some tickers to check out based on Q3 hedge fund activity
Tickers most initiated or closed by bioHF in Q3 '23
Most initiated
$RYZB $APGE $TSHE $SGMT $IMVT $SLNO $CMPS $GOSS
Most closed
$BDTX $VIR $THRX $MRSN
More details ...
👇 Initiated by the most bioHFs in Q3 '23
• Based on 9/30/23 13F filings
⇨ 2 newly IPOed
RYZB (10 vs. 0) (# bioHFs that held ticker on 9/30/23 vs. 6/30/23)
9/19/23 IPO
Ph1 SCLC & endocrine tumors
RYZB pipeline

APGE (9 vs. 0)
7/13/23 IPO
Ph1 Atopic derm
APGE pipeline

⇨ 1 more with very early stage assets
TSHA (8 vs. 0) (^2)
Ph1/2 Rett Syndrome
TSHA pipeline

⇨ 1 whose stock took a big plunge since end of Q3
SGMT (5 vs. 0)
Stock heading down since end Q2 (~12.50 to ~$3.63) but no readouts?
Upcoming Ph2b catalyst (Q1 2024) in NASH
SGMT 1 yr stock chart

⇨ 2 that had big mover positive readouts near end of last quarter
IMVT (14 vs. 6)
9/26/23
Ph1 auto-immune disease
IMVT-14-2 anti-FcRn Ab for various auto-immune diseases
pipeline in asset-type asset
IMVT 1 yr stock chart

SLNO (7 vs. 1)
9/26/23
Ph3 in PWS (rare disease - hyperphagia - eating disorder)
SLNO 1 yr stock chart

⇨ 1 with an important upcoming readout
CMPS (7 vs. 1)
Ph3 depression - Summer 2024
Only Deep Track had it previously
CMPS pipeline

⇨ 1 whose stock was crushed at end of 2022
GOSS (10 vs 5)
Lots of bioHFs for a micro-cap
EV <$200M
4 top 20s is high too
Ph2 update 12/18/23 for only clinical asset
GOSS stock chart

👇 As far as bioHF positions closed,
Not as many closed as initiated
⇨ Most bioHF closed in Q3 '23
Positions closed by 3 HFs
BDTX (5 vs. 8)
VIR (2 vs. 5)
THRX (3 vs. 6)
MRSN (8 vs. 11)
SUMMARY
These tickers are good ones to dig deeper into
Or if you already hold these tickers
take the info above as reinforcing, or a caution
^1 We identified & follow moves of 36 top BioHFs
⇨ That focus on biopharma stocks & have over $250M in AUM
^2 Confirm with your Hedge Fund data provider that there were no holdings for this ticker in Q2 to assure our provider's data is accurate, since the move from 0 to 8 is quite unusual for a company that went public before Q2
This article is not investment, tax, or legal advice. Please do your own diligence and seek advice from professional advisors representing your interests.
Article history:
Posted 12/20/23 (EJV)

Comments